ASXCompletion of FDA Inspection of New Manufacturing Facility
other announcement
EBR
EBR Systems
Health Care Equipment & Services
EBR Systems Inc. is a medical device company specializing in innovative solutions for cardiac rhythm management, focusing on leadless pacing technology. Their WiSE System offers a unique, physiologic approach to treating heart failure, setting them apart in the healthcare equipment sector.
Short position
short percentage0.27%
reported shorts2.3M
shares on issue845.411M
EBR Systems (ASX:EBR) has 0.27% of its shares on issue reported as short positions as of 5 Oct 2026, or about 2,263,673 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has risen 0.13 percentage points. Its highest recorded short interest was 0.53% in September 2024. EBR is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4EBR Systems (EBR) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Upcoming Australian Investor Conferences
other announcement
StockheadEBR lands higher US Medicare reimbursement for WiSE cardiac pacing
The US Centers for Medicare & Medicaid Services has finalised an increased Medicare inpatient reimbursement pathway for WiSE under the ... Read More The post EBR lands higher US Medicare reimbursement for WiSE cardiac pacing appeared first on Stockhead.
CMS Finalises Increased Inpatient Reimbursement for WiSE
other announcement
EBR aligns with FDA on WiSE cardiac pacing labelling
The company plans to submit a Changes Being Effected Premarket Approval supplement to the US Food and Drug Administration in ... Read More The post EBR aligns with FDA on WiSE cardiac pacing labelling appeared first on Stockhead.
EBR FDA Plan for Addressing Echo-induced Pacing Risks
other announcement
KalkineWhy is EBR Systems (ASX:EBR) All Ordinaries under regulatory review after its cybersecurity incident?
Highlights EBR Systems updated the market on a regulatory review after a cybersecurity incident. How regulatory communication and product safeguards frame the healthcare technology update. Read alongside EBR Systemss existing operating narrative, the disclosure refines rather than replaces what the market already knew. According to the latest release from EBR Systems (ASX:EBR), a member of the [All Ordinaries], EBR Systems updated the market on a regulatory review after a cybersecurity incide...
FDA Initiates Inspection of New Manufacturing Facility
other announcement
Update on FDA Review of Cybersecurity Incident
other announcement
New EBR manufacturing facility in US clears quality milestone
The facility in California had achieved ISO 13485 certification following an assessment by global standards and certification body the British ... Read More The post New EBR manufacturing facility in US clears quality milestone appeared first on Stockhead.
Google NewsEBR Systems (ASX:EBR): Could the Next Catalyst Put This ASX Name Back in Focus? - kalkine.com.au
EBR Systems (ASX:EBR): Could the Next Catalyst Put This ASX Name Back in Focus? kalkine.com.au
New Manufacturing Facility Achieves ISO Certification
other announcement
EBR Systems (ASX:EBR) WiSE Implant Milestone Strengthens Growth Outlook While Funding Risks Remain - Kalkine
EBR Systems (ASX:EBR) WiSE Implant Milestone Strengthens Growth Outlook While Funding Risks Remain Kalkine
EBR hits 100th WiSE implant during quarter as US rollout gathers pace
The WiSE system was implanted in 46 commercial patients during Q2 CY26, taking total commercial implants across its pilot launch ... Read More The post EBR hits 100th WiSE implant during quarter as US rollout gathers pace appeared first on Stockhead.
EBR Systems (ASX:EBR) Shares Trail A Revenue Surge As Losses Deepen - simplywall.st
EBR Systems (ASX:EBR) Shares Trail A Revenue Surge As Losses Deepen simplywall.st
EBR Systems (ASX:EBR) Shares in Focus as Investors Watch Cardiac Technology Developments - Kalkine
EBR Systems (ASX:EBR) Shares in Focus as Investors Watch Cardiac Technology Developments Kalkine
EBR Systems (ASX:EBR) Balances WiSE Commercial Growth Against Funding Risk - Kalkine
EBR Systems (ASX:EBR) Balances WiSE Commercial Growth Against Funding Risk Kalkine
Why Is EBR Systems (ASX:EBR) Gaining Attention in the ASX Healthcare Space?
Highlights EBR Systems is in focus after a fresh company disclosure added new context to the public record. The healthcare stocks lens centres on clinical progress, regulatory pathways, commercial execution and funding discipline. The broader Australian market backdrop remains important when reading company-specific developments. Australian shares are being assessed against a shifting mix of company updates, sector conditions and global market signals, making fresh disclosures especially impo...
Q2 2026 Quarterly Activity Report and Form 10-Q Submission
other announcement
EBR Systems (ASX:EBR) Shares Slip as Investors Assess Cardiac Technology Market Position - Kalkine
EBR Systems (ASX:EBR) Shares Slip as Investors Assess Cardiac Technology Market Position Kalkine
EBR to Attend Canaccord 46th Annual Growth Conference
other announcement
Launch of WiSE Coupler Accessory for U.S. Commercial Use
other announcement
Special Meeting of Stockholders and Preliminary Proxy
other announcement
Dr Boreham’s Crucible: EBR gets Wise to a US opportunity worth billions
EBR Systems is seeing encouraging signs from the US rollout of its wireless Wise pacemaker for heart failure patients with ... Read More The post Dr Boreham’s Crucible: EBR gets Wise to a US opportunity worth billions appeared first on Stockhead.
Bronwyn Evans Bought 54% More Shares In EBR Systems - simplywall.st
Bronwyn Evans Bought 54% More Shares In EBR Systems simplywall.st
ASX: EBR — EBR Systems Raises the Bar as Medtech Capital Markets Stay Tough - Kalkine
ASX: EBR — EBR Systems Raises the Bar as Medtech Capital Markets Stay Tough Kalkine
Form 8-K - Entry into a Material Definitive Agreement
other announcement
Notice of Dispatch of Retail Entitlement Offer Documents
capital_raise announcement
Biocurious: EBR Systems raises the bar in a sluggish capital raising climate
EBR Systems' $150 million cap raising takes the 12-month sectoral tally to almost $1.5 billion – but issuers aren't having ... Read More The post Biocurious: EBR Systems raises the bar in a sluggish capital raising climate appeared first on Stockhead.
Long Shortz with EBR: $150m cap raise marks significant milestone on path to profitability
Host Tylah Tully sits down with EBR Systems CEO and President John McCutcheon to discuss the company's fully underwritten $150 ... Read More The post Long Shortz with EBR: $150m cap raise marks significant milestone on path to profitability appeared first on Stockhead.
EBR Systems (ASX:EBR) Launches $150m Capital Raise, Shares Stumble - Kalkine
EBR Systems (ASX:EBR) Launches $150m Capital Raise, Shares Stumble Kalkine
EBR raises $150 million to turbocharge its US heart device rollout
EBR launches $150 million capital raise to support US commercial expansion of its groundbreaking WISE heart device. ... Read More The post EBR raises $150 million to turbocharge its US heart device rollout appeared first on Stockhead.
EBR Systems (ASX:EBR) lands CMS gate with March 2027 Medicare date - Stocks Down Under
EBR Systems (ASX:EBR) lands CMS gate with March 2027 Medicare date Stocks Down Under